NCT01949662 2026-02-13
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT02200172 2016-07-19
The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study
Bruyère Health Research Institute.
Phase 2 Completed
NCT01687751 2015-05-25
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
Phase 2 Withdrawn